Citius Pharmaceuticals (CTXR) 10-Q2025 Q1 Quarterly report

Filed: 14 Feb 25, 4:30pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: administered, authorized, automatic, balance, batch, broker, building, commitment, coordinating, covering, death, deferral, effort, GAAP, guarantor, HC, headcount, history, immune, infrastructure, inhibiting, inhibitor, intended, inventory, modulating, Nevada, outcome, pathway, penalty, promoting, proprietary, protein, Provisional, published, ratio, recapitalization, renewal, retroactively, role, runway, Secretary, service, shareholder, source, SpinCo, supply, table, vital, Volatility, WO, World

Removed: add, adversely, analytical, analyze, Anderson, announced, behalf, breast, catheter, cellular, Center, confirmation, contemplated, converted, CRL, customary, data, delay, domesticate, dose, efficacy, enhanced, enrolled, enrollment, enter, exempt, existing, final, formulation, gain, govern, halobetasol, high, incorporate, individual, Jersey, letter, Licensor, lidocaine, lock, meaningful, merge, migrate, observed, outlined, package, propionate, referred, registration, remediation, requested, require, respiratory, respond, Response, restated, resubmission, review, Rule, safety, salvage, scientific, shared, spinoff, stabilize, symptom, syndrome, System, testing, tolerated, Transfer, ultimate, unanimously, University, valuation, warrant

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CTXR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER AND THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Citius Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Leonard Mazur, Chief Executive Officer and Chairman Company, and Jaime Bartushak, Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

February 14, 2025	By:	/s/ Leonard Mazur
		Leonard Mazur
		Chief Executive Officer and Chairman
		(Principal Executive Officer)

	By:	/s/ Jaime Bartushak
		Jaime Bartushak
		Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.